Strides Pharma Science consolidated net profit declines 43.28% in the September 2020 quarter
Sales rise 10.97% to Rs 793.56 crore
Net profit of Strides Pharma Science declined 43.28% to Rs 80.95 crore in the quarter ended September 2020 as against Rs 142.72 crore during the previous quarter ended September 2019. Sales rose 10.97% to Rs 793.56 crore in the quarter ended September 2020 as against Rs 715.09 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales793.56715.09 11 OPM %16.6317.68 -PBDT122.75107.85 14 PBT69.9665.85 6 NP80.95142.72 -43Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 29 2020 | 3:42 PM IST